Waypoint Capital Advisors, LLC Neogenomics Inc Transaction History

Waypoint Capital Advisors, LLC

  • $407 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023
BUY
$6.45 - $12.07 $134,514 - $251,719
20,855 New
20,855 $0
Q2 2022

Jul 18, 2022
SELL
$7.06 - $13.97 $151,239 - $299,265
-21,422 Closed
0 $0
Q1 2022

Apr 19, 2022
BUY
$12.15 - $35.28 $260,277 - $755,768
21,422 New
21,422 $285,000

Others Institutions Holding NEO

# of Institutions
291
Shares Held
124M
Call Options Held
698K
Put Options Held
120K
View Full List

About NEOGENOMICS INC

NEO Quotes by TradingView
  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.82B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Waypoint Capital Advisors, LLC Portfolio

Follow Waypoint Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Waypoint Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Waypoint Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email